Adia Med, Inc. - 10-Q Filing
Adia Med, Inc. reports third quarter fiscal 2026 results with revenue segments spanning biologics, medical procedures, and supplements.
Tickers: $ADIA
Read the full article at SEC EDGAR
Part of the story Adia Med, Inc. - 10-Q Filing (2 articles)